CLINICAL TRIALS PROFILE FOR ESTRONE
✉ Email this page to a colleague
All Clinical Trials for ESTRONE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00010712 ↗ | Effects of Black Cohosh on Menopausal Hot Flashes | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 2 | 1999-09-01 | This study will assess whether treatment with black cohosh is effective in reducing the frequency and intensity of menopausal hot flashes. In addition, this study will determine whether or not black cohosh reduces the frequency of other menopausal symptoms and improves quality of life. |
| NCT00187655 ↗ | Effect of, OAT3, on the Renal Secretion of Cefotaxime | Completed | University of California, San Francisco | Phase 1 | 2004-01-01 | In the proposed study, we plan to use a genotype to phenotype strategy to study the role of the organic anion transporter, OAT3, in drug response. More specifically we will examine the contribution of OAT3 to the renal clearance of anionic drugs such as cefotaxime by studying individuals with a non-functional (or poorly-functional) variant of OAT3. |
| NCT00217659 ↗ | S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer | Withdrawn | National Cancer Institute (NCI) | Phase 2 | 2005-09-01 | RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer. |
| NCT00217659 ↗ | S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer | Withdrawn | Southwest Oncology Group | Phase 2 | 2005-09-01 | RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer. |
| NCT00228956 ↗ | Aromatase Inhibitor Clinical Trial | Unknown status | Indiana University School of Medicine | 2005-01-01 | You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form. | |
| NCT00228956 ↗ | Aromatase Inhibitor Clinical Trial | Unknown status | National Institute of Environmental Health Sciences (NIEHS) | 2005-01-01 | You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form. | |
| NCT00228956 ↗ | Aromatase Inhibitor Clinical Trial | Unknown status | Office of Research on Women's Health (ORWH) | 2005-01-01 | You are invited to participate in a research study looking at metabolism (breakdown) and effects of aromatase inhibitors. The purpose of this research is to try to identify which women who take an aromatase inhibitor are more likely to have certain benefits or side effects from the drug. We will do so by determining whether there are differences that normally occur in genes that you have inherited from your parents that might influence the way individuals respond to medications. If you agree to participate in this study, you will be asked to sign this informed consent form. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ESTRONE
Condition Name
Clinical Trial Locations for ESTRONE
Trials by Country
Clinical Trial Progress for ESTRONE
Clinical Trial Phase
Clinical Trial Sponsors for ESTRONE
Sponsor Name
